Copy

Sponsored by  

 

Daily Recap

When hard data are ‘heartbreaking’: Testing blitz in San Francisco shows Covid-19 struck mostly low-wage workers

By Usha Lee McFarling

Courtesy Barbara Ries

The testing project is proving to be a national model, because of the challenges the organizers overcame and what it showed about the spread of Covid-19.

Read More

Opinion: He was a ‘force of nature’: Anthony Fauci, Tom Frieden, and others remember Larry Kramer

By Patrick Skerrett

Angel Franco/The New York Times

Larry Kramer made it his life's work to change how people perceived AIDS, those living with it, and how medical research was done in the U.S.

Read More

Wastewater testing gains traction as a Covid-19 early warning system

By Sharon Begley

Justin Sullivan/Getty Images

What a month ago had been merely an intriguing lab finding about testing wastewater to detect the coronavirus has leapt to the threshold of real-world use.

Read More

STAT Plus: Bacteria are widespread in tumors, forming distinct populations depending on the cancer type

By Elizabeth Cooney

Khuloud T. Al-Jamal, David McCarthy & Izzat Suffian/Wellcome

In a comprehensive survey of bacteria in human tumor samples, scientists have discovered distinct populations of microbes in different types of tumors.

Read More

STAT Plus: A biotech company tries to retrofit a lung drug to prevent Covid-19’s after effects

By Damian Garde

FeatureChina via AP

PureTech Health, a biotech company in Boston, believes it might have a treatment for Covid-19 survivors facing the risk of long-term lung injuries.

Read More

Big gene therapy names line up behind experimental Covid-19 vaccine

By Matthew Herper

EMILIE PICKERING FOR STAT

An early stage vaccine is drawing interest from James Wilson, a gene therapy pioneer, as well as AveXis, the gene therapy unit of the drug giant Novartis.

Read More

Pharma leaders shoot down WHO voluntary pool for patent rights on Covid-19 products

By Ed Silverman

Drew Angerer/Getty Images

At a forum Thursday, pharma leaders expressed resistance to a voluntary WHO pool to collect patent rights that could be useful in the pandemic response.

Read More

Opinion: Challenge trials can speed development of a Covid-19 vaccine. Planning for them needs to start now

By Josh Morrison

Adobe

Challenge trials, in which volunteers are infected with SARS-CoV-2, can speed the development of a vaccine, but only if we start preparing for them now.

Read More

Thursday, May 28, 2020

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2020, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us
5cP.gif?contact_status=<<Contact Status>>